Intraocular Lens Injectors Market - Top Companies and Manufacturers

  • Report ID: 6032
  • Published Date: May 15, 2024
  • Report Format: PDF, PPT

Companies Dominating the Intraocular Lens Injectors Landscape

    The intraocular lens injectors market consists of a number of key players. These key players are launching various strategic initiatives to expand their market position in the intraocular lens injectors industry.

    • SpyGlass Pharma
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Alcon
    • Bausch Health Companies, Inc.
    • Carl Zeiss AG
    • Johnson & Johnson Services, Inc.
    • The Cooper Companies, Inc.
    • EssilorLuxottica
    • Ziemer Ophthalmic Systems AG
    • Staar Surgical
    • Haag-Streit AG

Browse Key Market Insights with Data Illustration:

In the News

  • SpyGlass Pharma announced 1-year follow-up information from a first-in-human study of 23 patients with glaucoma or ocular hypertension introduced with SpyGlass’ Intraocular Lens (IOL) based Drug Delivery Platform with bimatoprost during the time of cataract surgery. 
  • Alcon announced that it has launched Clareonfamily of intraocular lenses (IOLs) in the United States. Using Alcon’s most innovative IOL material, Clareon may deliver continuous visual outcomes and exceptional clarity that lasts.

Author Credits:  Radhika Pawar


  • Report ID: 6032
  • Published Date: May 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of intraocular lens injectors was over USD 4.30 billion.

The market size for intraocular lens injectors is predicted to cross USD 6.21 billion by the end of 2036 expanding at a CAGR of 3.10% during the forecast period i.e., between 2024-2036.

The major players in the market are SpyGlass Pharma, Alcon, Bausch Health Companies, Inc., Carl Zeiss AG, and others.

The preloaded intraocular lens injectors segment is anticipated to garner a share of 40% during 2024-2036.

The North America intraocular lens injectors sector is poised to hold a 30% share by the end of 2036.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample